An anti-inflammatory compound may have the potential to treat systemic inflammation and brain injury in patients with severe COVID-19 and significantly reduce their chances of death, according to a new study from UTHealth Houston and other institutions.
Anti-inflammatory compound shows potential in treating patients with severe COVID-19
July 20, 2022
Related blog posts
New drug shows promise for fighting both COVID-19 and cancer
November 15, 2022